News

Photo of Christopher Barbieri, M.D., Ph.D.

2021 May 17

Molecular Characterization Can Help Predict How Prostate Cancer Will Behave

Molecular characteristics detected in prostate cancers can provide clues that help predict how the disease will progress, according to new research from investigators at Weill Cornell Medicine and NewYork-Presbyterian. The... Read more

2021 May 10

Dr. Dan Landau's Study New Mapping Technique Reveals Epigenetic Drivers of Cancers

Scientists have made major advances in understanding and developing treatments for many cancers by identifying genetic mutations that drive the disease. Now a team led by researchers at Weill Cornell Medicine, NewYork-... Read more

2021 May 06

Two Grants Aim to Increase Access to Care and Clinical Trials for Queens and Brooklyn Patients with Blood Cancers

Weill Cornell Medicine has received complementary grants from Genentech and the Leukemia & Lymphoma Society (LLS) to support a new program that aims to address socioeconomic and racial disparities and increase access to... Read more

2021 Apr 27

Dr. Erica Phillips's Inaugural Marie Metoyer Award: WCM 2021 Pioneers in Diversity Awards

Weill Cornell Medicine honored more than two dozen faculty, trainees, students and staff April 26 for their outstanding service and leadership in promoting diversity at the academic medical institution. The annual Diversity... Read more

2021 Apr 26

Low Income Drives Financial Stress, Cancer-Related Worry and Anxiety Among Women with Gynecologic Cancers During Pandemic

Patients with gynecologic cancers who have Medicaid coverage are more likely to feel increased financial distress, anxiety about their cancer and increased general anxiety during the pandemic if their annual income is less... Read more

2021 Apr 23

Dr. David Lyden's Induction into Association of American Physicians

Weill Cornell Medicine physician-scientist Dr. David Lyden , whose research has led to groundbreaking discoveries about how cancer spreads, has been elected into the esteemed Association of American Physicians. Dr. Lyden,... Read more

Cancer immunologist Sandra Demaria, M.D., of the Meyer Cancer Center, is using radiation to transform tumors into personalized vaccines

2021 Mar 26

Study in Mice Suggests Radiation Therapy May Be an Important Addition to Personalized Vaccination for Cancer

Radiation therapy appears to increase or upregulate the expression of genes with mutations that induce an immune response to malignant cells, according to preclinical research by Weill Cornell Medicine and NewYork-... Read more

2021 Mar 22

Apostolou Lab's Study: Understanding and Exploiting “Cell Identity Crisis” Provides Potential New Routes to Stem Cell Therapy, Cancer Treatment

Molecular "bookmarks," which allow cells to retain their characteristics during cell division, ensure fast reactivation of critical cell identity genes after cell division, according to investigators at Weill Cornell... Read more

2021 Mar 12

Dr. Melnick's Study Finds Cancer Cells May Evade Chemotherapy by Going Dormant

Cancer cells can dodge chemotherapy by entering a state that bears similarity to certain kinds of senescence, a type of “active hibernation” that enables them to weather the stress induced by aggressive treatments aimed at... Read more

2021 Feb 17

Landau Lab's Super-Sensitive Cancer Blood Test Earns “Top 10” Award from Clinical Research Forum

Cancer biologists at Weill Cornell Medicine have been awarded a 2021 Top 10 Clinical Research Achievement Award from the Clinical Research Forum for their study last year describing a highly sensitive blood test for... Read more

2021 Feb 04

Dr. Cerchietti's Findings - Tumor Microenvironment Seen as a New Player in Aggressive Lymphomas

The environment surrounding the cancerous cells of a lymphoma tumor has a strong influence on the progression of these blood-cell cancers and their responses to therapies, according to a study by Weill Cornell Medicine... Read more

2021 Feb 01

Dr. Melnick's Study - Scientists Identify Gene that Plays Critical Role in Immune Cell Development

Much of the three-dimensional architecture of the genome in antibody-producing immune cells is dependent on a gene called SMC3. When this gene is not working properly it can lead to improper immune cell development and to... Read more

2021 Jan 15

New Collaborations Awarded Funding from Starr Cancer Consortium

The Starr Cancer Consortium has awarded grant funding to three Weill Cornell Medicine-led multi-institution teams to advance their groundbreaking cancer research projects. The grants will support studies on mechanisms that... Read more

2021 Jan 15

Dr. Manuel Hidalgo Shows that Organoids Derived from Patients Can Inform Pancreatic Cancer Research

Scientists in recent years have found that tumor cells biopsied from cancer patients can be grown in the lab into specialized tissues called organoids that mimic many aspects of the organ from which they are derived. Now... Read more

2020 Nov 20

Dr. Jorge Moscat-Guillen's Study Published in Developmental Cell

Congratulations to Dr. Jorge Moscat-Guillen and co-author, Dr. Maria Diaz-Meco , on their publication, Research Reveals Why Some Tumors Have Different Makeup of Cells , which was published in Developmental Cell. Molecular... Read more

2020 Aug 20

Dr. Lewis Cantley Awarded Johnson & Johnson Dr. Paul Janssen Award for Biomedical Research

Johnson & Johnson Celebrates Role of Scientists In Society with 2020 Dr. Paul Janssen Award for Biomedical Research, Part of the Champions of Science® Initiative. Lewis Cantley, Ph.D. Named 2020 Award Winner for the... Read more

2020 Jun 25

Dr. Jorge Moscat-Guillen's Study Published in Cancer Cell

Congratulations to Dr. Jorge Moscat-Guillen and co-author, Dr. Maria Diaz-Meco , on their publication, PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression , which was... Read more

2020 May 11

Dr. Lewis Cantley's episode on Peter Attia, M.D. blog: Episode #110 – Cancer metabolism, cancer therapies, and the discovery of PI3K

#110 – Lew Cantley, Ph.D.: Cancer metabolism, cancer therapies, and the discovery of PI3K " If I get a result that suddenly doesn't make sense, to me that's more exciting. . .if you figure out why it didn't work and what was... Read more

2020 Mar 23

Dr. Dan Landau's Study Illuminates Early Steps on the Road to Blood Cancers

Gene mutations that are thought to be very early events in the development of leukemias and other blood disorders appear to set the stage for malignancy by increasing the production of certain types of blood cells at the... Read more

2020 Feb 10

Most Comprehensive Whole-Genome Cancer Study To Date Catalogs Tumor-Driving Mutations

The scope of the DNA changes that drive cancers has been illuminated as never before in a set of studies by a large international scientific team including Weill Cornell Medicine researchers. In six studies published Feb. 5... Read more